NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that it will be presenting at the Ribosomes 2010 Conference, May 3-7, in Orvieto, Italy. The presentations include overviews on the design of next generation antibiotics and the Company’s proprietary platform for unlocking the bacterial ribosome, allowing for the design and generation of novel antibiotics.
